GlaxoSmithKline plc (GSK) today announced results from the 'LABA' (long acting beta 2-agonist) safety study, AUSTRI(SAS115359). The study compared Advair ® Diskus ®, a combination of the LABA, ...
Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...
WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...
The FDA also expanded the use of Advair Diskus 250/50 to a broader patient population which includes not only patients with COPD associated with chronic bronchitis, but also emphysema or both ...
Does the world's bestselling asthma drug sometimes kill the patients it is supposed to help? Frank A. Dittig was recovering from a nasty bout of pneumonia in the spring of 2004 when he developed a ...
TORONTO, RESEARCH PARK, N.C. According to new research, GlaxoSmithKline’s asthma drug Advair Diskus 250/50 demonstrated a 30 percent reduction in exacerbations in patients with chronic obstructive ...
Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and 25° C) ...
A strict new warning may impact sales of one of the world's top-selling asthma drugs. GlaxoSmithKline said today it had reached an agreement to update its product label for its popular drug Advair ...
U.S. regulators gave GlaxoSmithKline's ($GSK) Advair the green light a decade and a half ago, paving the way for a long reign that saw the med grow to more than $8 ...
ROCKVILLE, Maryland (Reuters) - GlaxoSmithKline Plc's widely prescribed drug Advair is safe enough for treating asthma but two lesser-used medicines are too risky, a U.S. advisory panel ruled on ...
Advair 250/50 Now the Only Treatment Approved to Both Reduce Exacerbations and Improve Lung Function RESEARCH TRIANGLE PARK, N.C., May 1 -- Late yesterday the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results